glp 1 pro life science 1LIFESCIENCE GLP-1 Probiotic Blend+ 60 Veggie caps 1 secretion from the guts L GLP-1 Daily Support – Swanson

Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program

Nonetheless, the financial burden obesity places on healthcare systems is significant

DPP4 inhibitors anti-fibrotic activities have also been demonstrated in various renal fibrosis models, such as the unilateral ureteral obstruction (UUO) model

Given that Mounjaro became the best-selling drug in Indian history, and has a better weight-loss profile than Sema (with similar side effects), Im confident the same dynamic will play out in the UK and US when semaglutide goes off patent in 2032